Medlab Clinical (ASX:MDC) EV-to-Revenue : 32.17 (As of Jun. 21, 2024)

View and export this data going back to 2015. Start your Free Trial

What is Medlab Clinical EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Medlab Clinical's enterprise value is A$11.00 Mil. Medlab Clinical's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.34 Mil. Therefore, Medlab Clinical's EV-to-Revenue for today is 32.17.

The historical rank and industry rank for Medlab Clinical's EV-to-Revenue or its related term are showing as below:

ASX:MDC' s EV-to-Revenue Range Over the Past 10 Years
Min: -3.36 Med: 14.4 Max: 88.16
Current: 32.17

During the past 8 years, the highest EV-to-Revenue of Medlab Clinical was 88.16. The lowest was -3.36. And the median was 14.40.

ASX:MDC's EV-to-Revenue is not ranked
in the Biotechnology industry.
Industry Median: 7.54 vs ASX:MDC: 32.17

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-21), Medlab Clinical's stock price is A$6.60. Medlab Clinical's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.15. Therefore, Medlab Clinical's PS Ratio for today is 44.00.

Medlab Clinical EV-to-Revenue Historical Data

The historical data trend for Medlab Clinical's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medlab Clinical EV-to-Revenue Chart

Medlab Clinical Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

EV-to-Revenue

Get a 7-Day Free Trial

11.67

11.77

8.56

9.38

16.64

Medlab Clinical Semi-Annual Data
	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial												-	9.38	-	16.64	-

Competitive Comparison of Medlab Clinical's EV-to-Revenue

For the Biotechnology subindustry, Medlab Clinical's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medlab Clinical's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medlab Clinical's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Medlab Clinical's EV-to-Revenue falls into.

Medlab Clinical EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Medlab Clinical's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	11.003	/	0.342
	=	32.17

Medlab Clinical's current Enterprise Value is A$11.00 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medlab Clinical's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.34 Mil.

Medlab Clinical (ASX:MDC) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Medlab Clinical's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	6.60	/	0.15
	=	44.00

Medlab Clinical's share price for today is A$6.60.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was A$0.15.

Medlab Clinical EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Medlab Clinical's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Medlab Clinical (ASX:MDC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medlab Clinical Ltd (ASX:MDC) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

11 Lord Street, Unit 5, Botany, NSW, AUS, 2019

Website

https://www.medlab.co

Medlab Clinical Ltd is a medical research and development company. It is engaged in researching and formulating novel biotherapeutics to improve health outcomes in early to moderate stage chronic diseases such as chronic kidney disease, pre-diabetes, and obesity. Some of the company's nutraceutical products are Multibiotic, Mg Optima Relax, NRGBiotic, NanoCelle D3, SB 5B and others. The principal segments of the group are Nutraceutical which includes the sale of nutraceutical products; and Pharmaceutical research. It generates the majority of the revenue from the sale of nutraceutical products. The business operations of the firm are carried out from Australia.